\[[PMC free article: PMC3953387](/pmc/articles/PMC3953387/)\] \[[PubMed: 24625749](https://pubmed.ncbi.nlm.nih.gov/24625749)\] 44. Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler S, Hamburg RJ, Ali N, Obermueller SD, Triana JF, Zimmerman JL. Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med. 1994 Sep 01;331(9):561-6. \[[PubMed: 7702648](https://pubmed.ncbi.nlm.nih.gov/7702648)\] 45. Chaitman BR, Alexander KP, Cyr DD, Berger JS, Reynolds HR, Bangalore S, Boden WE, Lopes RD, Demkow M, Piero Perna G, Riezebos RK, McFalls EO, Banerjee S, Bagai A, Gosselin G, O'Brien SM, Rockhold FW, Waters DD, Thygesen KA, Stone GW, White HD, Maron DJ, Hochman JS., ISCHEMIA Research Group. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. Circulation. 2021 Feb 23;143(8):790-804. \[[PMC free article: PMC7902479](/pmc/articles/PMC7902479/)\] \[[PubMed: 33267610](https://pubmed.ncbi.nlm.nih.gov/33267610)\] 46. Han S, Xu H, Zheng J, Sun J, Feng X, Wang Y, Ye W, Ke Q, Ren Y, Yao S, Zhang S, Chen J, Griggs RC, Zhao Z, Qi M, Gatheridge MA. Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing. Biomed Res Int. 2020;2020:8396429. \[[PMC free article: PMC7537677](/pmc/articles/PMC7537677/)\] \[[PubMed: 33029525](https://pubmed.ncbi.nlm.nih.gov/33029525)\] 47. Zheng J, Han S, Ye W, Yao S, Qi M, Chen J, Xu H. [Carrier screening model for Duchenne muscular dystrophy for women of reproductive age based on a pre-pregnancy birth defect control platform]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021 May 10;38(5):485-487. \[[PubMed: 33974262](https://pubmed.ncbi.nlm.nih.gov/33974262)\] 48. Gatheridge MA, Kwon JM, Mendell JM, Scheuerbrandt G, Moat SJ, Eyskens F, Rockman-Greenberg C, Drousiotou A, Griggs RC. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review. JAMA Neurol. 2016 Jan;73(1):111-6. \[[PubMed: 26594870](https://pubmed.ncbi.nlm.nih.gov/26594870)\] 49. Lee T, Tokunaga S, Taniguchi N, Misaki M, Shimomura H, Nishino I, Itoh K, Takeshima Y. Underlying diseases in sporadic presentation of high creatine kinase levels in girls. Clin Chim Acta. 2021 Aug;519:198-203. \[[PubMed: 33965408](https://pubmed.ncbi.nlm.nih.gov/33965408)\] 50. Finsterer J, Stöllberger C, Krugluger W. Significance of CK-elevation in noncompaction with regard to cardiac and neuromuscular disease. Int J Cardiol. 2008 Nov 12;130(2):174-9. \[[PubMed: 18055044](https://pubmed.ncbi.nlm.nih.gov/18055044)\] 51. Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med. 2009 Oct;67(9):272-83. \[[PubMed: 19841484](https://pubmed.ncbi.nlm.nih.gov/19841484)\] 52. Chatzizisis YS, Misirli G, Hatzitolios AI, Giannoglou GD. The syndrome of rhabdomyolysis: complications and treatment. Eur J Intern Med. 2008 Dec;19(8):568-74. \[[PubMed: 19046720](https://pubmed.ncbi.nlm.nih.gov/19046720)\] 53. Sauret JM, Marinides G, Wang GK. Rhabdomyolysis. Am Fam Physician. 2002 Mar 01;65(5):907-12. \[[PubMed: 11898964](https://pubmed.ncbi.nlm.nih.gov/11898964)\] 54. Brattebø G, Fredriksen